Arch or Enzyme Finance: Which Fits Your Crypto Plans?

Neither is a clear low-cost choice based on published pricing: Arch does not provide a complete schedule of investment, management, performance or withdrawal fees, and Enzyme does not publish complete pricing across its products. For Arch, the $250-equivalent bank deposit minimum (or CLP 250,000 in Chile) is a funding threshold, not a fee. Bank withdrawals have a $30-equivalent minimum. Its Digital, Preferente and Alto Patrimonio tiers have displayed entry amounts, but these should not be mistaken for fees or universal investment minimums.

Enzyme’s costs depend on whether you use Onyx, Blue or Myso, and its pricing should be confirmed for the specific service. On-chain activity may also incur network transaction costs, separate from platform charges. Before choosing either, request a written breakdown of every applicable charge, including any product-specific or ongoing costs. Without that comparison, you cannot reliably determine which will cost less for your intended use.

Neither platform’s listed audits establish that your funds cannot be lost. Both list two audits, but the auditors, dates and scope are not established. Ask which current products and deployed contracts the reports cover, and review the relevant findings before committing assets.

Arch says customer assets are separated, but its wallet setup and key control need clarification. It also says it is in the process of registering with Chile’s CMF; that is not the same as confirmed registration. Enzyme describes security controls and Vault infrastructure audits, but its custody model and applicable licensing also need confirmation. Its references to regulatory frameworks do not by themselves establish that Enzyme holds a licence or that a particular product complies where you operate.

For either choice, get written details on who controls assets, permissions, withdrawals or redemptions, and what happens if the service becomes unavailable. If regulatory status matters to you, verify the relevant entity and product for your jurisdiction before using it.

Arch is the more approachable option if you want an investment product rather than the tools to build one. You can sign up with an email address or connect a crypto wallet, then choose a fund and payment currency. Bank access is listed for Chile, Colombia, Mexico, Argentina and Peru; withdrawals typically take 24 hours, though that is not a guarantee. Arch says identity verification may be required before withdrawal if it is incomplete. Check the product and network before sending crypto: Arch lists Ethereum and Polygon, and an incorrect transfer can lead to loss.

Enzyme is more demanding if you are an individual looking for a simple app. It serves businesses, financial professionals and managers through product-specific access, documentation, APIs and SDKs. Features and networks can vary by product and deployment, so confirm the exact setup before transferring assets. Neither platform offers enough published pricing and custody detail to skip due diligence, but Enzyme also requires you to identify the relevant product and use case first.

Choose Arch if you want exposure to Bitcoin or diversified crypto portfolios through managed products, and you can use its supported Latin American bank routes or a crypto wallet. Its service tiers and optional personal support may appeal if you want assistance, but check how each product works, how returns are generated, what it costs and who controls the assets. Bitcoin+ is described as earning interest, but the source and variability of that interest need clarification.

Choose Enzyme Finance if you are issuing or administering a tokenized fund, curating on-chain strategies, or assessing options products. Onyx, Blue and Myso address different needs, with APIs and SDKs for technical teams. That range is useful for organizations but does not make Enzyme a substitute for a consumer investment app. Confirm product availability, deployment, pricing, custody, legal terms and network support for your specific project before proceeding. The reported TVL figures are not dated, so they should not decide the comparison.